viewMarrone Bio Innovations

Marrone Bio Innovations boosts credit facility to $23M

It boosted an existing accounts receivable credit facility to $20 million and added a $3 million inventory-backed credit facility

Marrone Bio Innovations -
The new facilities are thanks to a deal with LSQ Funding Group

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Thursday that it had expanded its credit facility to $23 million to support the biotech firm’s expansion. 

The Davis, California-based company boosted its existing accounts receivable credit facility by $13 million to a total of $20 million and added a $3 million inventory-backed credit facility to bring the total amount available to $23 million. 

The new facilities are thanks to a deal with LSQ Funding Group, which may purchase up to $20 million of eligible customer invoices from Marrone, a figure that represents a significant boost from the $7 million-ceiling agreed upon in 2017, the firm said in a statement. 

READ: Marrone Bio biofungicides win EPA approval for use on hemp plants

The substantial increase reflects LSQ’s “continued confidence” in the growth of Marrone’s business, according to Dan Ambrico, CEO at LSQ.

“Our partnership with LSQ has given us excellent cost-effective financial vehicles by which we can improve our liquidity and working capital to accommodate our rapid growth,” said Jim Boyd, CFO of Marrone Bio Innovations.

“I expect these facilities to help address the seasonal demand and varying sales cycles across the various crops and customers we serve.”

Founded in 2006, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market.

Its suite of biologicals includes a bevy of bacteria strains and plant extracts that fight pests, control plant diseases and reduces stress from sun and water.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Marrone Bio Innovations

Price: 0.6967 USD

Market: NASDAQ
Market Cap: $101.39 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...



Eden Research CEO hails product approvals in Italy and Spain for organic farming

Eden Research plc's (LON:EDEN) Sean Smith speaks to Proactive London's Andrew Scott after announcing its sustainable biopesticide Mevalone has received certification for use in organic farming in two European Union countries - Spain and Italy. The certification follows the initial...

7 hours, 17 minutes ago

2 min read